Total Visits

Views
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks478

Total Visits Per Month

November 2025December 2025January 2026February 2026March 2026April 2026May 2026
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks13274027384021

File Visits

Views
HCV-coinfected patients receiving.pdf79

Top country views

Views
United States106
Germany98
Singapore60
Hong Kong46
Ireland39
Brazil34
Vietnam18
United Kingdom9
Japan9
Spain8

Top cities views

Views
Frankfurt am Main89
Ashburn49
Hong Kong46
Dublin39
San Jose10
Singapore10
Ho Chi Minh City7
Seoul7
Hanoi6
The Dalles6